Skip to main content
Clinical Trials/NCT01113853
NCT01113853
Completed
Not Applicable

Daily Monitoring of Exhaled Nitric Oxide in Asthmatic Patients Stopping Anti-inflammatory Treatment

Universita di Verona1 site in 1 country40 target enrollmentJanuary 2007
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Universita di Verona
Enrollment
40
Locations
1
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

Previous studies have demonstrated that exhaled nitric oxide can be useful to monitor the efficacy of anti-inflammatory treatment as well as to predict a risk of asthma relapse in asthmatic patients.

The aim of the present study is to evaluate the time course of exhaled nitric oxide in mild asthmatic patients, stopping regular treatment with inhaled corticosteroids, if it is possible, in relationship with symptoms and lung function.

Detailed Description

All patients were evaluated with pulmonary lung function, exhaled nitric oxide and peak expiratory flow (PEF) and fill in a personal diary for the first two weeks when patients are in treatment; the same evaluation will be made for other four weeks without treatment.

Registry
clinicaltrials.gov
Start Date
January 2007
End Date
January 2010
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Universita di Verona

Eligibility Criteria

Inclusion Criteria

  • mild asthmatic treated with low dose inhaled steroids for whom it has to be considered stop of steroid treatment according to GINA guidelines

Exclusion Criteria

  • age \< 5 years
  • chronic respiratory diseases

Outcomes

Primary Outcomes

Not specified

Study Sites (1)

Loading locations...

Similar Trials